Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Masimo Stock Declines Despite Solid Preliminary Q4 Revenues
11:56am, Thursday, 15'th Jan 2026
MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.
Masimo Corporation (MASI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
07:56pm, Wednesday, 14'th Jan 2026
Masimo Corporation (MASI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Masimo Announces Select Preliminary 2025 Financial Results
09:00am, Monday, 12'th Jan 2026
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended January 3, 2026. Preliminary Fourth Q
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of “Hold” from Analysts
01:24am, Sunday, 11'th Jan 2026
Shares of Masimo Corporation (NASDAQ: MASI - Get Free Report) have earned a consensus recommendation of "Hold" from the eight brokerages that are covering the firm, MarketBeat.com reports. One investm
FMS or MASI: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 09'th Jan 2026
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or Masimo (MASI). But which of these two companies is the best option for those looking f
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
09:00am, Wednesday, 07'th Jan 2026
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pa
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
01:55pm, Monday, 05'th Jan 2026
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks linger.
Consumer tech news roundup covering AI investments, semiconductor tensions, EV delivery updates, Big Tech strategy shifts, and policy developments shaping global technology markets.
Apple's Vision Pro Production Plans, Masimo's Quality Score Declines Despite Patent Win, And More: This Week In Appleverse
07:01am, Sunday, 04'th Jan 2026
Mixed bag of news for Apple as Masimo tumbles in quality despite patent win, on-device AI threatens data centers, and the Tim Cook-led company scales back Vision Pro production.
Apple's Rival Masimo Tumbles In Quality Despite $634 Million Patent Win Over iPhone-Maker
07:22am, Friday, 02'nd Jan 2026
Despite securing a massive $634 million legal victory against Apple Inc. (NASDAQ: AAPL), Masimo Corp. (NASDAQ: MASI) is flashing warning signals in its underlying fundamentals.
3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium
08:35am, Tuesday, 30'th Dec 2025
Rising HSA limits and higher Medicare premiums in 2026 could lift demand for chronic care devices from DexCom, ResMed and Masimo.
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
10:46am, Friday, 26'th Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Corient Private Wealth LLC Sells 17,624 Shares of Masimo Corporation $MASI
03:53am, Wednesday, 17'th Dec 2025
Corient Private Wealth LLC lowered its position in shares of Masimo Corporation (NASDAQ: MASI) by 5.1% in the second quarter, according to the company in its most recent 13F filing with the Securities
Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of “Hold” by Brokerages
01:43am, Wednesday, 17'th Dec 2025
Shares of Masimo Corporation (NASDAQ: MASI - Get Free Report) have been assigned an average recommendation of "Hold" from the eight analysts that are presently covering the firm, Marketbeat.com report
Masimo (MASI) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Wednesday, 10'th Dec 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
